About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
H
Enhancing the Impact of Immunotherapy in TNBC: IO Therapy Options in Early Stage Disease
By
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
FEATURING
Hope Rugo
November 28, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
18:15
Novartis Oncology
CDK4/6 Inhibitor in Postmenopausal Patients With HR+/HER2- mBC: Anal…
Feat.
G. Hortobagyi
Featured Video
17:04
Novartis Oncology
Discussion on Overall Survival Data Across 3 Phase III Trials in HR+…
Feat.
G. Hortobagyi
Related Content
AUTOPLAY
ON
28:34
Breast Health Global Initiative
Clinical Pathways for Early Diagnosis of Breast Cancer
26:31
Yale Cancer Center
The Myth of Early Detection of Breast Cancer
Feat.
D. Lannin
16:44
Heather McArthur
Modern Immune Therapy Strategies for Triple-Negative Breast Cancer
17:54
Heather McArthur
Modern Immune Therapy in ER, HR+/HER2-, HER2+ Breast Cancer
24:03
Holy Cross 9th Annual Winter Oncology Symposium
Early Stage Breast Cancer - Comparison of Trials of Genomic Assays -…
Feat.
R. L. Mahtani
07:43
Dana-Farber Cancer Institute
Study of Abemaciclib for Patients with RB-Positive, Triple Negative …
Feat.
S. Goel
10:12
Holy Cross 9th Annual Winter Oncology Symposium
Emerging Targets in HER-2 Negative, TNBC and HER-3 Positive Breast C…
Feat.
M. Abu-Khalaf
18:15
Baltic and Eurasia Masterclass in Clinical Oncology
Systemic Therapy for Early Breast Cancer: Treatment Strategies for P…
Feat.
O. Pagani
10:53
Baltic and Eurasia Masterclass in Clinical Oncology
Neoadjuvant Systemic Therapy for HER2 + Early Breast Cancer - Review…
Feat.
A. Česas
19:04
Baltic and Eurasia Masterclass in Clinical Oncology
Adjuvant Systemic Therapy for HER2 + Early Breast Cancer - Neratinib…
Feat.
A. Česas
10:04
12th ESO-EONS Masterclass in Oncology Nursing
Early Breast Cancer Treatment: Decisive Steps & Disease Complexi…
Feat.
O. Pagani
07:58
12th ESO-EONS Masterclass in Oncology Nursing
Triple Negative Disease: Adjuvant Therapy, Hormone Receptor + Diseas…
Feat.
O. Pagani
13:36
Baltic and Eurasia Masterclass in Clinical Oncology
Systemic Treatment of TNBC: Staging, BRCAness, Chemotherapy Prognost…
Feat.
E. Kharchenko
10:06
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
NCCN Guidelines Update for TNBC and HER2 Breast Cancer: Immunotherap…
Feat.
J. Abraham,
W. Gradishar
08:27
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
Therapeutic Options for Systemic Treatment of TNBC & New Data on…
Feat.
D. Hicks
15:23
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
Q&A on Clinical Data Behind Changing the Guidelines, Her2+ Testi…
Feat.
D. Hicks
18:38
Peter Schmid
Immunotherapy in Metastatic Triple Negative Breast Cancer: IMpassion…
07:40
Dana-Farber Cancer Institute
Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Br…
Feat.
S. Tolaney
09:46
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
Current Concept of Breast Cancer Vaccines: Study on HER2 Directed Va…
Feat.
G. Peoples
33:18
Elisa Krill-Jackson
Advances In Treatment of Early Breast Cancer: Tailoring Therapy Usin…